Atlas Trials

Kyverna Therapeutics

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kyverna Therapeutics

RecordFirmDate
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 (NCT07403188)Kyverna Therapeutics2025-11-24
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome (NCT06588491)Kyverna Therapeutics2024-09-25
KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis (NCT06384976)Kyverna Therapeutics2024-09-20
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis (NCT06193889)Kyverna Therapeutics2024-08-28
KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis (NCT06400303)Kyverna Therapeutics2024-08-06
KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis (NCT05938725)Kyverna Therapeutics2023-04-28
KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis (NCT06342960)Kyverna Therapeutics2022-12-01

Track Kyverna Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.